{arrow_up} Back to top

Risk Minimisation Materials

Search by company, common medicine name, or title of Risk Minimisation Material

Namuscla

Lupin Healthcare (UK) Ltd

{pdf_link}

Namuscla 167 mg hard capsules-Educational Guide-Minimising the risks of cardiac arrhythmia and severity of adverse reactions in those with hepatic impairment

{healthcare_pro_orange} For Healthcare Professionals
Important information on minimising the risks of cardiac arrhythmia and severity of adverse reactions in those with hepatic impairment

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?